Literature DB >> 18082388

Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity?

Anish Suri1, Matteo G Levisetti, Emil R Unanue.   

Abstract

One seminal aspect in autoimmune diabetes is antigen presentation of beta cell antigens by the diabetes-propensity class II histocompatibility molecules. The binding properties of I-Ag7 molecules are reviewed here and an emphasis is placed on their selection of peptides with a highly specific sequence motif, in which one or more acidic amino acids are found at the carboxy end interacting at the P9 anchoring site of I-Ag7. The reasons for the central role of I-Ag7 in the autoimmune response are analyzed. The insulin B chain segment 9-23 is a hot spot for T cell selection and a striking example of a weak MHC binding peptide that triggers autoreactivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18082388      PMCID: PMC2561945          DOI: 10.1016/j.coi.2007.10.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  47 in total

1.  The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form.

Authors:  Matteo G Levisetti; Anish Suri; Shirley J Petzold; Emil R Unanue
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

2.  Identification of two distinct properties of class II major histocompatibility complex-associated peptides.

Authors:  C A Nelson; S J Petzold; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

3.  The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.

Authors:  E Carrasco-Marin; J Shimizu; O Kanagawa; E R Unanue
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

4.  Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules.

Authors:  K Falk; O Rötzschke; S Stevanović; G Jung; H G Rammensee
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

5.  Breaking self-tolerance in nonobese diabetic mice.

Authors:  W M Ridgway; M Fassò; A Lanctot; C Garvey; C G Fathman
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

6.  Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice.

Authors:  D R Wegmann; M Norbury-Glaser; D Daniel
Journal:  Eur J Immunol       Date:  1994-08       Impact factor: 5.532

7.  Amino acid residues on the I-Ak alpha-chain required for the binding and stability of two antigenic peptides.

Authors:  C A Nelson; N Viner; S Young; S Petzold; C Benoist; D Mathis; E R Unanue
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

8.  Low avidity recognition of self-antigen by T cells permits escape from central tolerance.

Authors:  G Y Liu; P J Fairchild; R M Smith; J R Prowle; D Kioussis; D C Wraith
Journal:  Immunity       Date:  1995-10       Impact factor: 31.745

9.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.

Authors:  D Daniel; R G Gill; N Schloot; D Wegmann
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

10.  Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8.

Authors:  R M Chicz; W S Lane; R A Robinson; M Trucco; J L Strominger; J C Gorga
Journal:  Int Immunol       Date:  1994-11       Impact factor: 4.823

View more
  21 in total

Review 1.  Historical overview of immunological tolerance.

Authors:  Ronald H Schwartz
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

2.  I-Ag7 is subject to post-translational chaperoning by CLIP.

Authors:  Cornelia H Rinderknecht; Ning Lu; Oliver Crespo; Phi Truong; Tieying Hou; Nan Wang; Narendiran Rajasekaran; Elizabeth D Mellins
Journal:  Int Immunol       Date:  2010-06-13       Impact factor: 4.823

Review 3.  CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes.

Authors:  Kathryn Haskins; Anne Cooke
Journal:  Curr Opin Immunol       Date:  2011-09-12       Impact factor: 7.486

Review 4.  Checkpoints in lymphocyte development and autoimmune disease.

Authors:  Harald von Boehmer; Fritz Melchers
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

5.  The novel endosomal membrane protein Ema interacts with the class C Vps-HOPS complex to promote endosomal maturation.

Authors:  Sungsu Kim; Yogesh P Wairkar; Richard W Daniels; Aaron DiAntonio
Journal:  J Cell Biol       Date:  2010-03-01       Impact factor: 10.539

6.  Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes.

Authors:  George S Eisenbarth
Journal:  Diabetes       Date:  2010-04       Impact factor: 9.461

7.  Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4*04 anti-insulin B:9-23 alpha chains.

Authors:  Li Zhang; Jean M Jasinski; Masakazu Kobayashi; Bennett Davenport; Kelly Johnson; Howard Davidson; Maki Nakayama; Kathryn Haskins; George S Eisenbarth
Journal:  J Autoimmun       Date:  2009-03-16       Impact factor: 7.094

8.  Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect.

Authors:  Daniel R Brims; Jie Qian; Irene Jarchum; Leann Mikesh; Edith Palmieri; Udupi A Ramagopal; Vladimir N Malashkevich; Rodolfo J Chaparro; Torben Lund; Masakazu Hattori; Jeffrey Shabanowitz; Donald F Hunt; Stanley G Nathenson; Steven C Almo; Teresa P Dilorenzo
Journal:  Int Immunol       Date:  2010-01-21       Impact factor: 4.823

Review 9.  Update in endocrine autoimmunity.

Authors:  Mark S Anderson
Journal:  J Clin Endocrinol Metab       Date:  2008-10       Impact factor: 5.958

10.  Insufficient autoantigen presentation and failure of tolerance in a mouse model of rheumatoid arthritis.

Authors:  Jason Perera; Xiao Liu; Yuzhen Zhou; Nora E Joseph; Liping Meng; Jerrold R Turner; Haochu Huang
Journal:  Arthritis Rheum       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.